The role of the gut and microbes in the pathogenesis of spondyloarthritis

Research output: Contribution to journalArticle

41 Citations (Scopus)

Abstract

The intestinal microbiota is firmly implicated not only in the pathogenesis of inflammatory bowel disease (IBD) but increasingly also in the development of inflammation at extraintestinal tissue sites. Significant clinical, genetic, immunological, and microbiological overlap exists between IBD and spondyloarthritis (SpA), which indicates that pathophysiological mechanisms are shared between these diseases and may center on the intestinal microbiota. Recently, culture-independent techniques have enabled the microbiota in health and disease to be described in increasing detail. Moreover, functional studies have identified myriad host effector and regulatory pathways that shape or are shaped by this microbial community. We consider the complex relationship between SpA pathogenesis and gut microbes, with a discussion of how manipulation of the gut microbiota itself may be a promising future target for SpA therapy.

Original languageEnglish (US)
Pages (from-to)687-702
Number of pages16
JournalBest Practice and Research: Clinical Rheumatology
Volume28
Issue number5
DOIs
StatePublished - 2014

Fingerprint

Inflammatory Bowel Diseases
Culture Techniques
Microbiota
Inflammation
Health
Gastrointestinal Microbiome
Therapeutics

Keywords

  • Ankylosing spondylitis
  • Dysbiosis
  • Inflammatory bowel disease
  • Microbiota
  • Reactive arthritis
  • Spondyloarthritis

ASJC Scopus subject areas

  • Rheumatology

Cite this

@article{6378c5485129484f8736ec24c4cea4c9,
title = "The role of the gut and microbes in the pathogenesis of spondyloarthritis",
abstract = "The intestinal microbiota is firmly implicated not only in the pathogenesis of inflammatory bowel disease (IBD) but increasingly also in the development of inflammation at extraintestinal tissue sites. Significant clinical, genetic, immunological, and microbiological overlap exists between IBD and spondyloarthritis (SpA), which indicates that pathophysiological mechanisms are shared between these diseases and may center on the intestinal microbiota. Recently, culture-independent techniques have enabled the microbiota in health and disease to be described in increasing detail. Moreover, functional studies have identified myriad host effector and regulatory pathways that shape or are shaped by this microbial community. We consider the complex relationship between SpA pathogenesis and gut microbes, with a discussion of how manipulation of the gut microbiota itself may be a promising future target for SpA therapy.",
keywords = "Ankylosing spondylitis, Dysbiosis, Inflammatory bowel disease, Microbiota, Reactive arthritis, Spondyloarthritis",
author = "Mark Asquith and Dirk Elewaut and Phoebe Lin and Rosenbaum, {James (Jim)}",
year = "2014",
doi = "10.1016/j.berh.2014.10.018",
language = "English (US)",
volume = "28",
pages = "687--702",
journal = "Best Practice and Research in Clinical Rheumatology",
issn = "1521-6942",
publisher = "Bailliere Tindall Ltd",
number = "5",

}

TY - JOUR

T1 - The role of the gut and microbes in the pathogenesis of spondyloarthritis

AU - Asquith, Mark

AU - Elewaut, Dirk

AU - Lin, Phoebe

AU - Rosenbaum, James (Jim)

PY - 2014

Y1 - 2014

N2 - The intestinal microbiota is firmly implicated not only in the pathogenesis of inflammatory bowel disease (IBD) but increasingly also in the development of inflammation at extraintestinal tissue sites. Significant clinical, genetic, immunological, and microbiological overlap exists between IBD and spondyloarthritis (SpA), which indicates that pathophysiological mechanisms are shared between these diseases and may center on the intestinal microbiota. Recently, culture-independent techniques have enabled the microbiota in health and disease to be described in increasing detail. Moreover, functional studies have identified myriad host effector and regulatory pathways that shape or are shaped by this microbial community. We consider the complex relationship between SpA pathogenesis and gut microbes, with a discussion of how manipulation of the gut microbiota itself may be a promising future target for SpA therapy.

AB - The intestinal microbiota is firmly implicated not only in the pathogenesis of inflammatory bowel disease (IBD) but increasingly also in the development of inflammation at extraintestinal tissue sites. Significant clinical, genetic, immunological, and microbiological overlap exists between IBD and spondyloarthritis (SpA), which indicates that pathophysiological mechanisms are shared between these diseases and may center on the intestinal microbiota. Recently, culture-independent techniques have enabled the microbiota in health and disease to be described in increasing detail. Moreover, functional studies have identified myriad host effector and regulatory pathways that shape or are shaped by this microbial community. We consider the complex relationship between SpA pathogenesis and gut microbes, with a discussion of how manipulation of the gut microbiota itself may be a promising future target for SpA therapy.

KW - Ankylosing spondylitis

KW - Dysbiosis

KW - Inflammatory bowel disease

KW - Microbiota

KW - Reactive arthritis

KW - Spondyloarthritis

UR - http://www.scopus.com/inward/record.url?scp=84927965465&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927965465&partnerID=8YFLogxK

U2 - 10.1016/j.berh.2014.10.018

DO - 10.1016/j.berh.2014.10.018

M3 - Article

C2 - 25488778

AN - SCOPUS:84927965465

VL - 28

SP - 687

EP - 702

JO - Best Practice and Research in Clinical Rheumatology

JF - Best Practice and Research in Clinical Rheumatology

SN - 1521-6942

IS - 5

ER -